Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Aug 20, 2001	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950134-01-505696.pdf 0000950134-01-505696.rtf
Aug 14, 2001	NT 10-Q	Notification that form type 10-Q will be submitted late	View HTML 0000950134-01-505502.pdf 0000950134-01-505502.rtf
Jun 5, 2001	8-K	Report of unscheduled material events or corporate event	View HTML 0000950134-01-502816.pdf 0000950134-01-502816.rtf
May 14, 2001	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950134-01-501706.pdf 0000950134-01-501706.rtf
May 14, 2001	10-Q/A	Amendment to a previously filed 10-Q	View HTML 0000950134-01-501732.pdf 0000950134-01-501732.rtf
May 10, 2001	8-K	Report of unscheduled material events or corporate event	View HTML 0000950134-01-501417.pdf 0000950134-01-501417.rtf
Apr 12, 2001	10-K405	Annual report. The Regulation S-K Item 405 box on the cover page is checked	View HTML 0000950134-01-500173.pdf 0000950134-01-500173.rtf
Apr 3, 2001	NT 10-K	Notification that form 10-K will be submitted late	View HTML 0000950134-01-003167.pdf 0000950134-01-003167.rtf
Dec 12, 2000	POS AM	Post-effective amendment to an S-Type filing	View HTML 0000950134-00-010437.pdf 0000950134-00-010437.rtf
Nov 13, 2000	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950134-00-009454.pdf 0000950134-00-009454.rtf